The Biosynthesis and Catabolism of Galactosaminoglycans

Advances in Pharmacology

Volumn 53, Issue , 2006, Pages 69-115

  Prabhakar, Vikas ^a   Sasisekharan, Ram ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN ABC LYASE; CHONDROITIN SULFATE; DERMATAN SULFATE; GALACTOSAMINOGLYCAN; POLYSACCHARIDE;

ANIMAL; BLOOD CLOTTING; CARTILAGE; CHEMISTRY; HUMAN; METABOLISM; NEOPLASM; OSTEOARTHRITIS; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BLOOD COAGULATION; CARTILAGE; CHONDROITIN LYASES; CHONDROITIN SULFATES; DERMATAN SULFATE; HUMANS; NEOPLASMS; OSTEOARTHRITIS; POLYSACCHARIDES; SIGNAL TRANSDUCTION;

EID: 33846168150     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(05)53005-9     Document Type: Review

References (253)

1. Abeijon C., Mandon E.C., and Hirschberg C.B. Transporters of nucleotide sugars, nucleotide sulfate and ATP in the Golgi apparatus. Trends Biochem. Sci. 22 6 (1997) 203-207
2. Achur R.N., Valiyaveettil M., Alkhalil A., Ockenhouse C.F., and Gowda D.C. Characterization of proteoglycans of human placenta and identification of unique chondroitin sulfate proteoglycans of the intervillous spaces that mediate the adherence of Plasmodium falciparum-infected erythrocytes to the placenta. J. Biol. Chem. 275 51 (2000) 40344-40356
3. Achur R.N., Valiyaveettil M., and Gowda D.C. The low sulfated chondroitin sulfate proteoglycans of human placenta have sulfate group-clustered domains that can efficiently bind Plasmodium falciparum-infected erythrocytes. J. Biol. Chem. 278 13 (2003) 11705-11713
4. Alkhalil A., Achur R.N., Valiyaveettil M., Ockenhouse C.F., and Gowda D.C. Structural requirements for the adherence of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate proteoglycans of human placenta. J. Biol. Chem. 275 51 (2000) 40357-40364
5. Bai X., Zhou D., Brown J.R., Crawford B.E., Hennet T., and Esko J.D. Biosynthesis of the linkage region of glycosaminoglycans: Cloning and activity of galactosyltransferase II, the sixth member of the beta 1,3-galactosyltransferase family (beta 3GalT6). J. Biol. Chem. 276 51 (2001) 48189-48195
6. Bechard D., Gentina T., Delehedde M., Scherpereel A., Lyon M., Aumercier M., Vazeux R., Richet C., Degand P., Jude B., Janin A., Fernig D.G., et al. Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. J. Biol. Chem. 276 51 (2001) 48341-48349
7. Beggah A.T., Dours-Zimmermann M.T., Barras F.M., Brosius A., Zimmermann D.R., and Zurn A.D. Lesion-induced differential expression and cell association of neurocan, brevican, versican V1 and V2 in the mouse dorsal root entry zone. Neuroscience 133 3 (2005) 749-762
8. Bendayan P., Boccalon H., Dupouy D., and Boneu B. Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins. Thromb. Haemost. 71 5 (1994) 576-580
9. Bielicki J., Hopwood J.J., Wilson P.J., and Anson D.S. Recombinant human iduronate-2-sulphatase: Correction of mucopolysaccharidosis-type II fibroblasts and characterization of the purified enzyme. Biochem. J. 289 Pt 1 (1993) 241-246
10. Bishop P.N. Structural macromolecules and supramolecular organization of the vitreous gel. Prog. Retin. Eye Res. 19 3 (2000) 323-344
11. Blakemore W.F., Chari D.M., Gilson J.M., and Crang A.J. Modelling large areas of demyelination in the rat reveals the potential and possible limitations of transplanted glial cells for remyelination in the CNS. Glia 38 2 (2002) 155-168
12. Bradbury E.J., Moon L.D., Popat R.J., King V.R., Bennett G.S., Patel P.N., Fawcett J.W., and McMahon S.B. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416 6881 (2002) 636-640
13. Brakebusch C., Seidenbecher C.I., Asztely F., Rauch U., Matthies H., Meyer H., Krug M., Bockers T.M., Zhou X., Kreutz M.R., Montag D., Gundelfinger E.D., et al. Brevican-deficient mice display impaired hippocampal CA1 long-term potentiation but show no obvious deficits in learning and memory. Mol. Cell. Biol. 22 21 (2002) 7417-7427
14. Brooks B., Briggs D.M., Eastmond N.C., Fernig D.G., and Coleman J.W. Presentation of IFN-gamma to nitric oxide-producing cells: A novel function for mast cells. J. Immunol. 164 2 (2000) 573-579
15. Brooks D.A. Alpha-L-iduronidase and enzyme replacement therapy for mucopolysaccharidosis I. Expert Opin. Biol. Ther. 2 8 (2002) 967-976
16. Buchanan M.R., and Brister S.J. Anticoagulant and antithrombin effects of intimatan, a heparin cofactor II agonist. Thromb. Res. 99 6 (2000) 603-612
17. Buchanan M.R., Maclean G.A., and Brister S.J. Selective and sustained inhibition of surface-bound thrombin activity by intimatan/heparin cofactor II and its relevance to assessing systemic anticoagulation in vivo, ex vivo and in vitro. Thromb. Haemost. 86 3 (2001) 909-913
18. Cardin A.D., and Weintraub H.J. Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 9 1 (1989) 21-32
19. Casu B., Choay J., Ferro D.R., Gatti G., Jacquinet J.C., Petitou M., Provasoli A., Ragazzi M., Sinay P., and Torri G. Controversial glycosaminoglycan conformations. Nature 322 6076 (1986) 215-216
20. Casu B., Guerrini M., and Torri G. Structural and conformational aspects of the anticoagulant and anti-thrombotic activity of heparin and dermatan sulfate. Curr. Pharm. Des. 10 9 (2004) 939-949
21. Casu B., Petitou M., Provasoli M., and Sinay P. Conformational flexibility: A new concept for explaining binding and biological properties of iduronic acid-containing glycosaminoglycans. Trends Biochem. Sci. 13 6 (1988) 221-225
22. Catlow K., Deakin J.A., Delehedde M., Fernig D.G., Gallagher J.T., Pavao M.S., and Lyon M. Hepatocyte growth factor/scatter factor and its interaction with heparan sulphate and dermatan sulphate. Biochem. Soc. Trans. 31 2 (2003) 352-353
23. Chai W., Beeson J.G., and Lawson A.M. The structural motif in chondroitin sulfate for adhesion of Plasmodium falciparum-infected erythrocytes comprises disaccharide units of 4-O-sulfated and non-sulfated N-acetylgalactosamine linked to glucuronic acid. J. Biol. Chem. 277 25 (2002) 22438-22446
24. Cheng F., Yoshida K., Heinegard D., and Fransson L.A. A new method for sequence analysis of glycosaminoglycans from heavily substituted proteoglycans reveals non-random positioning of 4- and 6-O-sulphated N-acetylgalactosamine in aggrecan-derived chondroitin sulphate. Glycobiology 2 6 (1992) 553-561
25. Coccheri S., Scondotto G., Agnelli G., Aloisi D., Palazzini E., and Zamboni V. Randomised, double blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers. Thromb. Haemost. 87 6 (2002) 947-952
26. Coccheri S., Scondotto G., Agnelli G., Palazzini E., and Zamboni V. Sulodexide in the treatment of intermittent claudication: Results of a randomized, double-blind, multicentre, placebo-controlled study. Eur. Heart J. 23 13 (2002) 1057-1065
27. Cogburn J.N., and Silbert J.E. The effect of penultimate N-acetylgalactosamine 4-sulfate on chondroitin chain elongation. Carbohydr. Res. 151 (1986) 207-212
28. Daniele A., Tomanin R., Villani G.R., Zacchello F., Scarpa M., and Di Natale P. Uptake of recombinant iduronate-2-sulfatase into neuronal and glial cells in vitro. Biochim. Biophys. Acta 1588 3 (2002) 203-209
29. DeAngelis P.L., and Padgett-McCue A.J. Identification and molecular cloning of a chondroitin synthase from Pasteurella multocida type F. J. Biol. Chem. 275 31 (2000) 24124-24129
30. Deepa S.S., Yamada S., Zako M., Goldberger O., and Sugahara K. Chondroitin sulfate chains on syndecan-1 and syndecan-4 from normal murine mammary gland epithelial cells are structurally and functionally distinct and cooperate with heparan sulfate chains to bind growth factors: A novel function to control binding of midkine, pleiotrophin, and basic fibroblast growth factor. J. Biol. Chem. 279 36 (2004) 37368-37376
31. Denholm E.M., Cauchon E., Poulin C., and Silver P.J. Inhibition of human dermal fibroblast proliferation by removal of dermatan sulfate. Eur. J. Pharmacol. 400 2-3 (2000) 145-153
32. Denholm E.M., Lin Y.Q., and Silver P.J. Anti-tumor activities of chondroitinase AC and chondroitinase B: Inhibition of angiogenesis, proliferation and invasion. Eur. J. Pharmacol. 416 3 (2001) 213-221
33. Denti A., Sini P., Tira M.E., and Balduini C. Structural heterogeneity of dermatan sulfate chains: Correlation with heparin cofactor II activating properties. Thromb. Res. 79 2 (1995) 187-198
34. Edgell C.J., BaSalamah M.A., and Marr H.S. Testican-1: A differentially expressed proteoglycan with protease inhibiting activities. Int. Rev. Cytol. 236 (2004) 101-122
35. Elefteriou F., Exposito J.Y., Garrone R., and Lethias C. Binding of tenascin-X to decorin. FEBS Lett. 495 1-2 (2001) 44-47
36. Enghild J.J., Salvesen G., Hefta S.A., Thogersen I.B., Rutherfurd S., and Pizzo S.V. Chondroitin 4-sulfate covalently cross-links the chains of the human blood protein pre-alpha-inhibitor. J. Biol. Chem. 266 2 (1991) 747-751
37. Ernst S., Langer R., Cooney C.L., and Sasisekharan R. Enzymatic degradation of glycosaminoglycans. Crit. Rev. Biochem. Mol. Biol. 30 5 (1995) 387-444
38. Esko J.D. Proteoglycans and glycosaminoglycans. In: Varki A. (Ed). "Essentials of Glycobiology" (1999), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 145-159
39. Esko J.D., and Zhang L. Influence of core protein sequence on glycosaminoglycan assembly. Curr. Opin. Struct. Biol. 6 5 (1996) 663-670
40. Evers M.R., Xia G., Kang H.G., Schachner M., and Baenziger J.U. Molecular cloning and characterization of a dermatan-specific N-acetylgalactosamine 4-O-sulfotransferase. J. Biol. Chem. 276 39 (2001) 36344-36353
41. Fawcett J.W., and Asher R.A. The glial scar and central nervous system repair. Brain Res. Bull. 49 6 (1999) 377-391
42. Fernandez J.A., Petaja J., and Griffin J.H. Dermatan sulfate and LMW heparin enhance the anticoagulant action of activated protein C. Thromb. Haemost. 82 (1999) 1462-1468
43. Ferro D.R., Provasoli A., Ragazzi M., Casu B., Torri G., Bossennec V., Perly B., Sinay P., Petitou M., and Choay J. Conformer populations of L-iduronic acid residues in glycosaminoglycan sequences. Carbohydr. Res. 195 2 (1990) 157-167
44. Fethiere J., Eggimann B., and Cygler M. Crystal structure of chondroitin AC lyase, a representative of a family of glycosaminoglycan degrading enzymes. J. Mol. Biol. 288 4 (1999) 635-647
45. Fransson L.A., and Coster L. Interaction between dermatan sulphate chains. II. Structural studies on aggregating glycan chains and oligosaccharides with affinity for dermatan sulphate-substituted agarose. Biochim. Biophys. Acta 582 1 (1979) 132-144
46. Fransson L.A., Havsmark B., and Silverberg I. A method for the sequence analysis of dermatan sulphate. Biochem. J. 269 2 (1990) 381-388
47. Freeze H.H. Degradation and turnover of glycans. In: Varki A. (Ed). "Essentials of Glycobiology" (1999), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 267-283
48. Frevert C.W., Kinsella M.G., Vathanaprida C., Goodman R.B., Baskin D.G., Proudfoot A., Wells T.N., Wight T.N., and Martin T.R. Binding of interleukin-8 to heparan sulfate and chondroitin sulfate in lung tissue. Am. J. Respir. Cell Mol. Biol. 28 4 (2003) 464-472
49. Frick I.M., Schmidtchen A., and Sjobring U. Interactions between M proteins of Streptococcus pyogenes and glycosaminoglycans promote bacterial adhesion to host cells. Eur. J. Biochem. 270 10 (2003) 2303-2311
50. Fukuta M., Kobayashi Y., Uchimura K., Kimata K., and Habuchi O. Molecular cloning and expression of human chondroitin 6-sulfotransferase. Biochim. Biophys. Acta 1399 1 (1998) 57-61
51. Fukuta M., Uchimura K., Nakashima K., Kato M., Kimata K., Shinomura T., and Habuchi O. Molecular cloning and expression of chick chondrocyte chondroitin 6-sulfotransferase. J. Biol. Chem. 270 31 (1995) 18575-18580
52. Gamain B., Gratepanche S., Miller L.H., and Baruch D.I. Molecular basis for the dichotomy in Plasmodium falciparum adhesion to CD36 and chondroitin sulfate A. Proc. Natl. Acad. Sci. USA 99 15 (2002) 10020-10024
53. Garcia-Olivas R., Hoebeke J., Castel S., Reina M., Fager G., Lustig F., and Vilaro S. Differential binding of platelet-derived growth factor isoforms to glycosaminoglycans. Histochem. Cell Biol. 120 5 (2003) 371-382
54. Garwood J., Rigato F., Heck N., and Faissner A. Tenascin glycoproteins and the complementary ligand DSD-1-PG/phosphacan: Structuring the neural extracellular matrix during development and repair. Restor. Neurol. Neurosci. 19 1-2 (2001) 51-64
55. Ghiselli G., and Iozzo R.V. Overexpression of bamacan/SMC3 causes transformation. J. Biol. Chem. 275 27 (2000) 20235-20238
56. Gotoh M., Yada T., Sato T., Akashima T., Iwasaki H., Mochizuki H., Inaba N., Togayachi A., Kudo T., Watanabe H., Kimata K., and Narimatsu H. Molecular cloning and characterization of a novel chondroitin sulfate glucuronyltransferase that transfers glucuronic acid to N-acetylgalactosamine. J. Biol. Chem. 277 41 (2002) 38179-38188
57. Gotting C., Kuhn J., Zahn R., Brinkmann T., and Kleesiek K. Molecular cloning and expression of human UDP-d-xylose: Proteoglycan core protein beta-d-xylosyltransferase and its first isoform XT-II. J. Mol. Biol. 304 4 (2000) 517-528
58. Grootenhuis P.D., van Boeckel C.A., and Haasnoot C.A. Carbohydrates and drug discovery: The role of computer simulation. Trends Biotechnol. 12 1 (1994) 9-14
59. Gu K., Liu J., Pervin A., and Linhardt R.J. Comparison of the activity of two chondroitin AC lyases on dermatan sulfate. Carbohydr. Res. 244 2 (1993) 369-377
60. Guo S., Sato T., Shirane K., and Furukawa K. Galactosylation of N-linked oligosaccharides by human beta-1,4-galactosyltransferases I, II, III, IV, V, and VI expressed in Sf-9 cells. Glycobiology 11 10 (2001) 813-820
61. Guthrie E.P., Shoemaker N.B., and Salyers A.A. Cloning and expression in Escherichia coli of a gene coding for a chondroitin lyase from Bacteroides thetaiotaomicron. J. Bacteriol. 164 2 (1985) 510-515
62. Habuchi H., Tanaka M., Habuchi O., Yoshida K., Suzuki H., Ban K., and Kimata K. The occurrence of three isoforms of heparan sulfate 6-O-sulfotransferase having different specificities for hexuronic acid adjacent to the targeted N-sulfoglucosamine. J. Biol. Chem. 275 4 (2000) 2859-2868
63. Habuchi O., Matsui Y., Kotoya Y., Aoyama Y., Yasuda Y., and Noda M. Purification of chondroitin 6-sulfotransferase secreted from cultured chick embryo chondrocytes. J. Biol. Chem. 268 29 (1993) 21968-21974
64. Hamai A., Hashimoto N., Mochizuki H., Kato F., Makiguchi Y., Horie K., and Suzuki S. Two distinct chondroitin sulfate ABC lyases: An endoeliminase yielding tetrasaccharides and an exoeliminase preferentially acting on oligosaccharides. J. Biol. Chem. 272 14 (1997) 9123-9130
65. Hardingham T.E., and Fosang A.J. Proteoglycans: Many forms and many functions. FASEB J. 6 3 (1992) 861-870
66. Harenberg J. Review of pharmacodynamics, pharmacokinetics, and therapeutic properties of sulodexide. Med. Res. Rev. 18 1 (1998) 1-20
67. Harroch S., Palmeri M., Rosenbluth J., Custer A., Okigaki M., Shrager P., Blum M., Buxbaum J.D., and Schlessinger J. No obvious abnormality in mice deficient in receptor protein tyrosine phosphatase beta. Mol. Cell. Biol. 20 20 (2000) 7706-7715
68. Hartmann U., and Maurer P. Proteoglycans in the nervous system: The quest for functional roles in vivo. Matrix Biol. 20 1 (2001) 23-35
69. Hayashi N., Miyata S., Yamada M., Kamei K., and Oohira A. Neuronal expression of the chondroitin sulfate proteoglycans receptor-type protein-tyrosine phosphatase beta and phosphacan. Neuroscience 131 2 (2005) 331-348
70. Hildebrand A., Romaris M., Rasmussen L.M., Heinegard D., Twardzik D.R., Border W.A., and Ruoslahti E. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem. J. 302 Pt 2 (1994) 527-534
71. Hiraoka N., Nakagawa H., Ong E., Akama T.O., Fukuda M.N., and Fukuda M. Molecular cloning and expression of two distinct human chondroitin 4-O-sulfotransferases that belong to the HNK-1 sulfotransferase gene family. J. Biol. Chem. 275 26 (2000) 20188-20196
72. Hiyama K., and Okada S. Action of chondroitinases. I. The mode of action of two chondroitinase-AC preparations of different origin. J. Biochem. (Tokyo) 80 6 (1976) 1201-1207
73. Hiyama K., and Okada S. Action of chondroitinases. III. Ionic strength effects and kinetics in the action of chondroitinase AC. J. Biochem. (Tokyo) 82 2 (1977) 429-436
74. Holland S.J., Peles E., Pawson T., and Schlessinger J. Cell-contact-dependent signalling in axon growth and guidance: Eph receptor tyrosine kinases and receptor protein tyrosine phosphatase beta. Curr. Opin. Neurobiol. 8 1 (1998) 117-127
75. Huang W., Boju L., Tkalec L., Su H., Yang H.O., Gunay N.S., Linhardt R.J., Kim Y.S., Matte A., and Cygler M. Active site of chondroitin AC lyase revealed by the structure of enzyme-oligosaccharide complexes and mutagenesis. Biochemistry 40 8 (2001) 2359-2372
76. Huang W., Lunin V.V., Li Y., Suzuki S., Sugiura N., Miyazono H., and Cygler M. Crystal structure of Proteus vulgaris chondroitin sulfate ABC lyase I at 1.9A resolution. J. Mol. Biol. 328 3 (2003) 623-634
77. Huang W., Matte A., Li Y., Kim Y.S., Linhardt R.J., Su H., and Cygler M. Crystal structure of chondroitinase B from Flavobacterium heparinum and its complex with a disaccharide product at 1.7 Å resolution. J. Mol. Biol. 294 5 (1999) 1257-1269
78. Hwa V., and Salyers A.A. Analysis of two chondroitin sulfate utilization mutants of Bacteroides thetaiotaomicron that differ in their abilities to compete with the wild type in the gastrointestinal tracts of germfree mice. Appl. Environ. Microbiol. 58 3 (1992) 869-876
79. Hwa V., and Salyers A.A. Evidence for differential regulation of genes in the chondroitin sulfate utilization pathway of Bacteroides thetaiotaomicron. J. Bacteriol. 174 1 (1992) 342-344
80. Hwang H.Y., Olson S.K., Esko J.D., and Horvitz H.R. Caenorhabditis elegans early embryogenesis and vulval morphogenesis require chondroitin biosynthesis. Nature 423 6938 (2003) 439-443
81. Imberti D., Verso M., Silvestrini E., Taliani M.R., and Agnelli G. Successful treatment with dermatan sulfate in six patients with heparin-induced thrombocytopenia and acute venous thromboembolism. J. Thromb. Haemost. 1 12 (2003) 2696-2697
82. Iozzo R.V. The family of the small leucine-rich proteoglycans: Key regulators of matrix assembly and cellular growth. Crit. Rev. Biochem. Mol. Biol. 32 2 (1997) 141-174
83. Iozzo R.V. Matrix proteoglycans: From molecular design to cellular function. Annu. Rev. Biochem. 67 (1998) 609-652
84. Iwata M., and Carlson S.S. A large chondroitin sulfate basement membrane-associated proteoglycan exists as a disulfide-stabilized complex of several proteins. J. Biol. Chem. 266 1 (1991) 323-333
85. Jackson R.L., Busch S.J., and Cardin A.D. Glycosaminoglycans: Molecular properties, protein interactions, and role in physiological processes. Physiol. Rev. 71 2 (1991) 481-539
86. Jandik K.A., Gu K., and Linhardt R.J. Action pattern of polysaccharide lyases on glycosaminoglycans. Glycobiology 4 3 (1994) 289-296
87. Jedrzejas M.J. Structural and functional comparison of polysaccharide-degrading enzymes. Crit. Rev. Biochem. Mol. Biol. 35 3 (2000) 221-251
88. Johnson W.E., Caterson B., Eisenstein S.M., and Roberts S. Human intervertebral disc aggrecan inhibits endothelial cell adhesion and cell migration in vitro. Spine 30 10 (2005) 1139-1147
89. Jourdian G.W. Normal and pathological catabolism of glycoproteins. New Compr. Biochem. 30 (1996) 3-54
90. Ju T., Brewer K., D'Souza A., Cummings R.D., and Canfield W.M. Cloning and expression of human core 1 beta1,3-galactosyltransferase. J. Biol. Chem. 277 1 (2002) 178-186
91. Kang H.G., Evers M.R., Xia G., Baenziger J.U., and Schachner M. Molecular cloning and characterization of chondroitin-4-O-sulfotransferase-3. A novel member of the HNK-1 family of sulfotransferases. J. Biol. Chem. 277 38 (2002) 34766-34772
92. Kawachi H., Fujikawa A., Maeda N., and Noda M. Identification of GIT1/Cat-1 as a substrate molecule of protein tyrosine phosphatase zeta/beta by the yeast substrate-trapping system. Proc. Natl. Acad. Sci. USA 98 12 (2001) 6593-6598
93. Kawashima H., Atarashi K., Hirose M., Hirose J., Yamada S., Sugahara K., and Miyasaka M. Oversulfated chondroitin/dermatan sulfates containing GlcAbeta1/IdoAalpha 1-3GalNAc(4,6-O-disulfate) interact with L- and P-selectin and chemokines. J. Biol. Chem. 277 15 (2002) 12921-12930
94. Kearns A.E., Vertel B.M., and Schwartz N.B. Topography of glycosylation and UDP-xylose production. J. Biol. Chem. 268 15 (1993) 11097-11104
95. Keyhani N.O., and Roseman S. The chitin catabolic cascade in the marine bacterium Vibrio furnissii: Molecular cloning, isolation, and characterization of a periplasmic beta-N-acetylglucosaminidase. J. Biol. Chem. 271 52 (1996) 33425-33432
96. Kinsella M.G., Bressler S.L., and Wight T.N. The regulated synthesis of versican, decorin, and biglycan: Extracellular matrix proteoglycans that influence cellular phenotype. Crit. Rev. Eukaryot. Gene Expr. 14 3 (2004) 203-234
97. Kitagawa H., Tanaka Y., Yamada S., Seno N., Haslam S.M., Morris H.R., Dell A., and Sugahara K. A novel pentasaccharide sequence GlcA(3-sulfate)(beta1-3)GalNAc(4-sulfate)(beta1-4)(Fuc alpha1-3)GlcA(beta1-3)GalNAc(4-sulfate) in the oligosaccharides isolated from king crab cartilage chondroitin sulfate K and its differential susceptibility to chondroitinases and hyaluronidase. Biochemistry 36 13 (1997) 3998-4008
98. Kitagawa H., Fujita M., Ito N., and Sugahara K. Molecular cloning and expression of a novel chondroitin 6-O-sulfotransferase. J. Biol. Chem. 275 28 (2000) 21075-21080
99. Kitagawa H., Tone Y., Tamura J., Neumann K.W., Ogawa T., Oka S., Kawasaki T., and Sugahara K. Molecular cloning and expression of glucuronyltransferase I involved in the biosynthesis of the glycosaminoglycan-protein linkage region of proteoglycans. J. Biol. Chem. 273 12 (1998) 6615-6618
100. Kitagawa H., Uyama T., and Sugahara K. Molecular cloning and expression of a human chondroitin synthase. J. Biol. Chem. 276 42 (2001) 38721-38726
101. Kitamikado M., and Lee Y.Z. Chondroitinase-producing bacteria in natural habitats. Appl. Microbiol. 29 3 (1975) 414-421
102. Knudson C.B., and Knudson W. Cartilage proteoglycans. Semin. Cell Dev. Biol. 12 2 (2001) 69-78
103. Kobayashi M., Sugumaran G., Liu J., Shworak N.W., Silbert J.E., and Rosenberg R.D. Molecular cloning and characterization of a human uronyl 2-sulfotransferase that sulfates iduronyl and glucuronyl residues in dermatan/chondroitin sulfate. J. Biol. Chem. 274 15 (1999) 10474-10480
104. Kolbinger F., Streiff M.B., and Katopodis A.G. Cloning of a human UDP-galactose: 2-acetamido-2-deoxy-D-glucose 3beta-galactosyltransferase catalyzing the formation of type 1 chains. J. Biol. Chem. 273 1 (1998) 433-440
105. Kovanen P.T., and Pentikainen M.O. Decorin links low-density lipoproteins (LDL) to collagen: A novel mechanism for retention of LDL in the atherosclerotic plaque. Trends Cardiovasc. Med. 9 3-4 (1999) 86-91
106. Kusche-Gullberg M., and Kjellen L. Sulfotransferases in glycosaminoglycan biosynthesis. Curr. Opin. Struct. Biol. 13 5 (2003) 605-611
107. Lander C., Kind P., Maleski M., and Hockfield S. A family of activity-dependent neuronal cell-surface chondroitin sulfate proteoglycans in cat visual cortex. J. Neurosci. 17 6 (1997) 1928-1939
108. Lee P.H., Trowbridge J.M., Taylor K.R., Morhenn V.B., and Gallo R.L. Dermatan sulfate proteoglycan and glycosaminoglycan synthesis is induced in fibroblasts by transfer to a three-dimensional extracellular environment. J. Biol. Chem. 279 47 (2004) 48640-48646
109. Lesley J., Hyman R., English N., Catterall J.B., and Turner G.A. CD44 in inflammation and metastasis. Glycoconj. J. 14 5 (1997) 611-622
110. Liaw P.C., Austin R.C., Fredenburgh J.C., Stafford A.R., and Weitz J.I. Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II. J. Biol. Chem. 274 39 (1999) 27597-27604
111. Liaw P.C., Becker D.L., Stafford A.R., Fredenburgh J.C., and Weitz J.I. Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor ii in the presence of dermatan sulfate but not heparin. J. Biol. Chem. 276 24 (2001) 20959-20965
112. Linhardt R.J., al-Hakim A., Liu J.A., Hoppensteadt D., Mascellani G., Bianchini P., and Fareed J. Structural features of dermatan sulfates and their relationship to anticoagulant and antithrombotic activities. Biochem. Pharmacol. 42 8 (1991) 1609-1619
113. Linhardt R.J., Galliher P.M., and Cooney C.L. Polysaccharide lyases. Appl. Biochem. Biotechnol. 12 2 (1986) 135-176
114. Linn S., Chan T., Lipeski L., and Salyers A.A. Isolation and characterization of two chondroitin lyases from Bacteroides thetaiotaomicron. J. Bacteriol. 156 2 (1983) 859-866
115. Litjens T., Brooks D.A., Peters C., Gibson G.J., and Hopwood J.J. Identification, expression, and biochemical characterization of N-acetylgalactosamine-4-sulfatase mutations and relationship with clinical phenotype in MPS-VI patients. Am. J. Hum. Genet. 58 6 (1996) 1127-1134
116. Liu D., Shriver Z., Venkataraman G., El Shabrawi Y., and Sasisekharan R. Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis. Proc. Natl. Acad. Sci. USA 99 2 (2002) 568-573
117. Lunin V.V., Li Y., Linhardt R.J., Miyazono H., Kyogashima M., Kaneko T., Bell A.W., and Cygler M. High-resolution crystal structure of Arthrobacter aurescens chondroitin AC lyase: An enzyme-substrate complex defines the catalytic mechanism. J. Mol. Biol. 337 2 (2004) 367-386
118. Lyle S., Stanczak J., Ng K., and Schwartz N.B. Rat chondrosarcoma ATP sulfurylase and adenosine 5′-phosphosulfate kinase reside on a single bifunctional protein. Biochemistry 33 19 (1994) 5920-5925
119. Lyon M., Deakin J.A., and Gallagher J.T. The mode of action of heparan and dermatan sulfates in the regulation of hepatocyte growth factor/scatter factor. J. Biol. Chem. 277 2 (2002) 1040-1046
120. Lyon M., Deakin J.A., Rahmoune H., Fernig D.G., Nakamura T., and Gallagher J.T. Hepatocyte growth factor/scatter factor binds with high affinity to dermatan sulfate. J. Biol. Chem. 273 1 (1998) 271-278
121. Maimone M.M., and Tollefsen D.M. Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity. J. Biol. Chem. 265 30 (1990) 18263-18271
122. Maimone M.M., and Tollefsen D.M. Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity. J. Biol. Chem. 266 22 (1991) 14830
123. Mardberg K., Trybala E., Tufaro F., and Bergstrom T. Herpes simplex virus type 1 glycoprotein C is necessary for efficient infection of chondroitin sulfate-expressing gro2C cells. J. Gen. Virol. 83 Pt 2 (2002) 291-300
124. Margolis R.K., and Margolis R.U. Nervous tissue proteoglycans. Experientia 49 5 (1993) 429-446
125. Marino M., Lisi S., Pinchera A., Marcocci C., Menconi F., Morabito E., Macchia M., Sellari-Franceschini S., McCluskey R.T., and Chiovato L. Glycosaminoglycans provide a binding site for thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy. Thyroid 13 9 (2003) 851-859
126. Mascellani G., Liverani L., Bianchini P., Parma B., Torri G., Bisio A., Guerrini M., and Casu B. Structure and contribution to the heparin cofactor II-mediated inhibition of thrombin of naturally oversulphated sequences of dermatan sulphate. Biochem. J. 296 Pt 3 (1993) 639-648
127. Masuno M., Tomatsu S., Nakashima Y., Hori T., Fukuda S., Masue M., Sukegawa K., and Orii T. Mucopolysaccharidosis IV A: Assignment of the human N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene to chromosome 16q24. Genomics 16 3 (1993) 777-778
128. Menozzi F.D., Pethe K., Bifani P., Soncin F., Brennan M.J., and Locht C. Enhanced bacterial virulence through exploitation of host glycosaminoglycans. Mol. Microbiol. 43 6 (2002) 1379-1386
129. Michalski J.-C. Normal and pathological catabolism of glycoproteins. New Compr. Biochem. 30 (1996) 55-97
130. Michel G., Pojasek K., Li Y., Sulea T., Linhardt R.J., Raman R., Prabhakar V., Sasisekharan R., and Cygler M. The structure of chondroitin B lyase complexed with glycosaminoglycan oligosaccharides unravels a calcium-dependent catalytic machinery. J. Biol. Chem. 279 31 (2004) 32882-32896
131. Michelacci Y.M., Horton D.S., and Poblacion C.A. Isolation and characterization of an induced chondroitinase ABC from Flavobacterium heparinum. Biochim. Biophys. Acta 923 2 (1987) 291-301
132. Mishima N., and Hoffman S. Neurocan in the embryonic avian heart and vasculature. Anat. Rec. A Discov. Mol. Cell Evol. Biol. 272 2 (2003) 556-562
133. Mitra A.K., Arnott S., Atkins E.D., and Isaac D.H. Dermatan sulfate: Molecular conformations and interactions in the condensed state. J. Mol. Biol. 169 4 (1983) 873-901
134. Mizuguchi S., Uyama T., Kitagawa H., Nomura K.H., Dejima K., Gengyo-Ando K., Mitani S., Sugahara K., and Nomura K. Chondroitin proteoglycans are involved in cell division of Caenorhabditis elegans. Nature 423 6938 (2003) 443-448
135. Monagle P., Berry L., O'Brodovich H., Andrew M., and Chan A. Covalent heparin cofactor II-heparin and heparin cofactor II-dermatan sulfate complexes: Characterization of novel anticoagulants. J. Biol. Chem. 273 50 (1998) 33566-33571
136. Monnier P.P., Sierra A., Schwab J.M., Henke-Fahle S., and Mueller B.K. The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar. Mol. Cell. Neurosci. 22 3 (2003) 319-330
137. Moon L.D., Asher R.A., Rhodes K.E., and Fawcett J.W. Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nat. Neurosci. 4 5 (2001) 465-466
138. Morgenstern D.A., Asher R.A., and Fawcett J.W. Chondroitin sulphate proteoglycans in the CNS injury response. Prog. Brain Res. 137 (2002) 313-332
139. Morris C.P., Guo X.H., Apostolou S., Hopwood J.J., and Scott H.S. Morquio A syndrome: Cloning, sequence, and structure of the human N-acetylgalactosamine 6-sulfatase (GALNS) gene. Genomics 22 3 (1994) 652-654
140. Moses J., Oldberg A., Eklund E., and Fransson L.A. Biosynthesis of the proteoglycan decorin: Identification of intermediates in galactosaminoglycan assembly. Eur. J. Biochem. 248 3 (1997) 767-774
141. Moses J., Oldberg A., and Fransson L.A. Initiation of galactosaminoglycan biosynthesis: Separate galactosylation and dephosphorylation pathways for phosphoxylosylated decorin protein and exogenous xyloside. Eur. J. Biochem. 260 3 (1999) 879-884
142. Murai S., Umemiya T., Seiki M., and Harigaya K. Expression and localization of membrane-type-1 matrix metalloproteinase, CD 44, and laminin-5gamma2 chain during colorectal carcinoma tumor progression. Virchows Arch. 445 3 (2004) 271-278
143. Nadanaka S., Fujita M., and Sugahara K. Demonstration of a novel sulfotransferase in fetal bovine serum, which transfers sulfate to the C6 position of the GalNAc residue in the sequence iduronic acid alpha1-3GalNAc beta1-4iduronic acid in dermatan sulfate. FEBS Lett. 452 3 (1999) 185-189
144. Nadanaka S., and Sugahara K. The unusual tetrasaccharide sequence GlcA beta 1-3GalNAc(4-sulfate)beta 1-4GlcA(2-sulfate)beta 1-3GalNAc(6-sulfate) found in the hexasaccharides prepared by testicular hyaluronidase digestion of shark cartilage chondroitin sulfate D. Glycobiology 7 2 (1997) 253-263
145. Nakanishi Y., Shimizu M., Otsu K., Kato S., Tsuji M., and Suzuki S. A terminal 6-sulfotransferase catalyzing a synthesis of N-acetylgalactosamine 4,6-bissulfate residue at the nonreducing terminal position of chondroitin sulfate. J. Biol. Chem. 256 11 (1981) 5443-5449
146. Natowicz M.R., Short M.P., Wang Y., Dickersin G.R., Gebhardt M.C., Rosenthal D.I., Sims K.B., and Rosenberg A.E. Clinical and biochemical manifestations of hyaluronidase deficiency. New Engl. J. Med. 335 14 (1996) 1029-1033
147. Nelimarkka L., Salminen H., Kuopio T., Nikkari S., Ekfors T., Laine J., Pelliniemi L., and Jarvelainen H. Decorin is produced by capillary endothelial cells in inflammation-associated angiogenesis. Am. J. Pathol. 158 2 (2001) 345-353
148. Nenci G.G. Dermatan sulphate as an antithrombotic drug. Pathophysiol. Haemost. Thromb. 32 5-6 (2002) 303-307
149. Nenci G.G., Gresele P., Ferrari G., Santoro L., and Gianese F. Treatment of intermittent claudication with mesoglycan-a placebo-controlled, double-blind study. Thromb. Haemostasis 86 5 (2001) 1181-1187
150. Neufeld E.F., and Muenzer J. The mucopolysaccharidoses. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). "The Metabolic and Molecular Bases of Inherited Disease" Vol. 3 (2001), McGraw-Hill, New York 3421-3452
151. Ninomiya T., Sugiura N., Tawada A., Sugimoto K., Watanabe H., and Kimata K. Molecular cloning and characterization of chondroitin polymerase from Escherichia coli strain K4. J. Biol. Chem. 277 24 (2002) 21567-21575
152. Nyberg K., Ekblad M., Bergstrom T., Freeman C., Parish C.R., Ferro V., and Trybala E. The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus. Antivir. Res. 63 1 (2004) 15-24
153. Oegema Jr. T.R., Kraft E.L., Jourdian G.W., and Van Valen T.R. Phosphorylation of chondroitin sulfate in proteoglycans from the swarm rat chondrosarcoma. J. Biol. Chem. 259 3 (1984) 1720-1726
154. Ofosu F.A. Pharmacological actions of sulodexide. Semin. Thromb. Hemost. 24 2 (1998) 127-138
155. Ohtake S., Ito Y., Fukuta M., and Habuchi O. Human N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase cDNA is related to human B cell recombination activating gene-associated gene. J. Biol. Chem. 276 47 (2001) 43894-43900
156. Okajima T., Yoshida K., Kondo T., and Furukawa K. Human homolog of Caenorhabditis elegans sqv-3 gene is galactosyltransferase I involved in the biosynthesis of the glycosaminoglycan-protein linkage region of proteoglycans. J. Biol. Chem. 274 33 (1999) 22915-22918
157. Olsson M., Thyberg J., and Nilsson J. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscl. Throm. Vas. 19 5 (1999) 1218-1222
158. Oohira A., Matsui F., Tokita Y., Yamauchi S., and Aono S. Molecular interactions of neural chondroitin sulfate proteoglycans in the brain development. Arch. Biochem. Biophys. 374 1 (2000) 24-34
159. Oohira A., Shuo T., Tokita Y., Nakanishi K., and Aono S. Neuroglycan C, a brain-specific part-time proteoglycan, with a particular multidomain structure. Glycoconjugate J. 21 1-2 (2004) 53-57
160. Ornitz D.M., Herr A.B., Nilsson M., Westman J., Svahn C.M., and Waksman G. FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides. Science 268 5209 (1995) 432-436
161. Oshima A., Kyle J.W., Miller R.D., Hoffmann J.W., Powell P.P., Grubb J.H., Sly W.S., Tropak M., Guise K.S., and Gravel R.A. Cloning, sequencing, and expression of cDNA for human beta-glucuronidase. Proc. Natl. Acad. Sci. USA 84 3 (1987) 685-689
162. Otsu K., Inoue H., Nakanishi Y., Kato S., Tsuji M., and Suzuki S. A sulfotransferase-sulfatase system in avian oviduct which catalyzes a conversion of UDP-N-acetylgalactosamine 4-sulfate to the 6-sulfate isomer. J. Biol. Chem. 259 10 (1984) 6403-6410
163. Parveen N., Caimano M., Radolf J.D., and Leong J.M. Adaptation of the Lyme disease spirochaete to the mammalian host environment results in enhanced glycosaminoglycan and host cell binding. Mol. Microbiol. 47 5 (2003) 1433-1444
164. Pennybacker M., Liessem B., Moczall H., Tifft C.J., Sandhoff K., and Proia R.L. Identification of domains in human beta-hexosaminidase that determine substrate specificity. J. Biol. Chem. 271 29 (1996) 17377-17382
165. Petersen F., Bock L., Flad H.D., and Brandt E. A chondroitin sulfate proteoglycan on human neutrophils specifically binds platelet factor 4 and is involved in cell activation. J. Immunol. 161 8 (1998) 4347-4355
166. Petersen F., Brandt E., Lindahl U., and Spillmann D. Characterization of a neutrophil cell surface glycosaminoglycan that mediates binding of platelet factor 4. J. Biol. Chem. 274 18 (1999) 12376-12382
167. Plaas A.H., West L., Midura R.J., and Hascall V.C. Disaccharide composition of hyaluronan and chondroitin/dermatan sulfate: Analysis with fluorophore-assisted carbohydrate electrophoresis. Methods Mol. Biol. 171 (2001) 117-128
168. Plaas A.H., West L.A., Wong-Palms S., and Nelson F.R. Glycosaminoglycan sulfation in human osteoarthritis: Disease-related alterations at the non-reducing termini of chondroitin and dermatan sulfate. J. Biol. Chem. 273 20 (1998) 12642-12649
169. Pojasek K., Raman R., Kiley P., Venkataraman G., and Sasisekharan R. Biochemical characterization of the chondroitinase B active site. J. Biol. Chem. 277 34 (2002) 31179-31186
170. Pojasek K., Shriver Z., Kiley P., Venkataraman G., and Sasisekharan R. Recombinant expression, purification, and kinetic characterization of chondroitinase AC and chondroitinase B from Flavobacterium heparinum. Biochem. Biophys. Res. Commun. 286 2 (2001) 343-351
171. Poole A.R. Proteoglycans in health and disease: Structures and functions. Biochem. J. 236 1 (1986) 1-14
172. Popp S., Andersen J.S., Maurel P., and Margolis R.U. Localization of aggrecan and versican in the developing rat central nervous system. Dev. Dynam. 227 1 (2003) 143-149
173. Prabhakar V., Capila I., Bosques C.J., Pojasek K., and Sasisekharan R. Chondroitinase ABC I from Proteus vulgaris: Cloning, recombinant expression and active site identification. Biochem. J. 386 Pt 1 (2005) 103-112
174. Priglinger U., Geiger M., Bielek E., Vanyek E., and Binder B.R. Binding of urinary protein C inhibitor to cultured human epithelial kidney tumor cells (TCL-598): The role of glycosaminoglycans present on the luminal cell surface. J. Biol. Chem. 269 20 (1994) 14705-14710
175. Properzi F., Asher R.A., and Fawcett J.W. Chondroitin sulphate proteoglycans in the central nervous system: Changes and synthesis after injury. Biochem. Soc. Trans. 31 2 (2003) 335-336
176. Proudfoot A.E., Fritchley S., Borlat F., Shaw J.P., Vilbois F., Zwahlen C., Trkola A., Marchant D., Clapham P.R., and Wells T.N. The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity. J. Biol. Chem. 276 14 (2001) 10620-10626
177. Prydz K., and Dalen K.T. Synthesis and sorting of proteoglycans. J. Cell Sci. 113 Pt 2 (2000) 193-205
178. Ragan P.M., Chin V.I., Hung H.H., Masuda K., Thonar E.J., Arner E.C., Grodzinsky A.J., and Sandy J.D. Chondrocyte extracellular matrix synthesis and turnover are influenced by static compression in a new alginate disk culture system. Arch. Biochem. Biophys. 383 2 (2000) 256-264
179. Rauch U., Zhou X.H., and Roos G. Extracellular matrix alterations in brains lacking four of its components. Biochem. Biophys Res. Commun. 328 2 (2005) 608-617
180. Rautela G.S., and Abramson C. Crystallization and partial characterization of Staphylococcus aureus hyaluronate lyase. Arch. Biochem. Biophys. 158 2 (1973) 687-694
181. Reed C.C., Waterhouse A., Kirby S., Kay P., Owens R.T., McQuillan D.J., and Iozzo R.V. Decorin prevents metastatic spreading of breast cancer. Oncogene 24 6 (2005) 1104-1110
182. Ryan M.J., Khandke K.M., Tilley B.C., and Lotvin J.A. Cloning and expression of the chondroitinase I and II genes from P. vulgaris (1994) (international application published under the patent cooperation treaty) WO 94/25567.
183. Rye C.S., and Withers S.G. Development of an assay and determination of kinetic parameters for chondroitin AC lyase using defined synthetic substrates. Anal. Biochem. 308 1 (2002) 77-82
184. Rye C.S., and Withers S.G. Elucidation of the mechanism of polysaccharide cleavage by chondroitin AC lyase from Flavobacterium heparinum. J. Am. Chem. Soc. 124 33 (2002) 9756-9767
185. Rye C.S., and Withers S.G. Synthesis and evaluation of potential inhibitors of chondroitin AC lyase from Flavobacterium heparinum. J. Org. Chem. 67 13 (2002) 4505-4512
186. Sadler J.E. Thrombomodulin structure and function. Thromb. Haemostasis 78 1 (1997) 392-395
187. Saito H., Yamagata T., and Suzuki S. Enzymatic methods for the determination of small quantities of isomeric chondroitin sulfates. J. Biol. Chem. 243 7 (1968) 1536-1542
188. Sanderson R.D., Yang Y., Suva L.J., and Kelly T. Heparan sulfate proteoglycans and heparanase-partners in osteolytic tumor growth and metastasis. Matrix Biol. 23 6 (2004) 341-352
189. Sasisekharan R., Bulmer M., Moremen K.W., Cooney C.L., and Langer R. Cloning and expression of heparinase I gene from Flavobacterium heparinum. Proc. Natl. Acad. Sci. USA 90 8 (1993) 3660-3664
190. Sasisekharan R., and Venkataraman G. Heparin and heparan sulfate: Biosynthesis, structure and function. Curr. Opin. Chem. Biol. 4 6 (2000) 626-631
191. Sato N., Shimada M., Nakajima H., Oda H., and Kimura S. Cloning and expression in Escherichia coli of the gene encoding the Proteus vulgaris chondroitin ABC lyase. Appl. Microbiol. Biotechnol. 41 1 (1994) 39-46
192. Saunders S., Paine-Saunders S., and Lander A.D. Expression of the cell surface proteoglycan glypican-5 is developmentally regulated in kidney, limb, and brain. Dev. Biol. 190 1 (1997) 78-93
193. Schmidtchen A., Frick I.M., and Bjorck L. Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial alpha-defensin. Mol. Microbiol. 39 3 (2001) 708-713
194. Schreuder H.A., de Boer B., Dijkema R., Mulders J., Theunissen H.J., Grootenhuis P.D., and Hol W.G. The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions. Nat. Struct. Biol. 1 1 (1994) 48-54
195. Schumacher S., Volkmer H., Buck F., Otto A., Tarnok A., Roth S., and Rathjen F.G. Chicken acidic leucine-rich EGF-like domain containing brain protein (CALEB), a neural member of the EGF family of differentiation factors, is implicated in neurite formation. J. Cell. Biol. 136 4 (1997) 895-906
196. Scott H.S., Anson D.S., Orsborn A.M., Nelson P.V., Clements P.R., Morris C.P., and Hopwood J.J. Human alpha-L-iduronidase: cDNA isolation and expression. Proc. Natl. Acad. Sci. USA 88 21 (1991) 9695-9699
197. Scott J.E., Chen Y., and Brass A. Secondary and tertiary structures involving chondroitin and chondroitin sulphates in solution, investigated by rotary shadowing/electron microscopy and computer simulation. Eur. J. Biochem. 209 2 (1992) 675-680
198. Sheng W., Wang G., Wang Y., Liang J., Wen J., Zheng P.S., Wu Y., Lee V., Slingerland J., Dumont D., and Yang B.B. The roles of versican V1 and V2 isoforms in cell proliferation and apoptosis. Mol. Biol. Cell 16 3 (2005) 1330-1340
199. Shipley J.M., Grubb J.H., and Sly W.S. The role of glycosylation and phosphorylation in the expression of active human beta-glucuronidase. J. Biol. Chem. 268 16 (1993) 12193-12198
200. Shriver Z., Raguram S., and Sasisekharan R. Glycomics: A pathway to a class of new and improved therapeutics. Nat. Rev. Drug Discov. 3 10 (2004) 863-873
201. Silbert J.E. Biosynthesis of chondroitin sulfate: Chain termination. J. Biol. Chem. 253 19 (1978) 6888-6892
202. Silbert J.E., and DeLuca S. Biosynthesis of chondroitin sulfate. 3. Formation of a sulfated glycosaminoglycan with a microsomal preparation from chick embryo cartilage. J. Biol. Chem. 244 3 (1969) 876-881
203. Silbert J.E., and Freilich L.S. Biosynthesis of chondroitin sulphate by a Golgi-apparatus-enriched preparation from cultures of mouse mastocytoma cells. Biochem. J. 190 2 (1980) 307-313
204. Silbert J.E., and Reppucci Jr. A.C. Biosynthesis of chondroitin sulfate: Independent addition of glucuronic acid and N-acetylgalactosamine to oligosaccharides. J. Biol. Chem. 251 13 (1976) 3942-3947
205. Silbert J.E., and Sugumaran G. Biosynthesis of chondroitin/dermatan sulfate. IUBMB Life 54 4 (2002) 177-186
206. Stacey M., Chang G.W., Davies J.Q., Kwakkenbos M.J., Sanderson R.D., Hamann J., Gordon S., and Lin H.H. The epidermal growth factor-like domains of the human EMR2 receptor mediate cell attachment through chondroitin sulfate glycosaminoglycans. Blood 102 8 (2003) 2916-2924
207. Streit A., Nolte C., Rasony T., and Schachner M. Interaction of astrochondrin with extracellular matrix components and its involvement in astrocyte process formation and cerebellar granule cell migration. J. Cell Biol. 120 3 (1993) 799-814
208. Sugahara K., and Kitagawa H. Heparin and heparan sulfate biosynthesis. IUBMB Life 54 4 (2002) 163-175
209. Sugahara K., Masuda M., Harada T., Yamashina I., de Waard P., and Vliegenthart J.F. Structural studies on sulfated oligosaccharides derived from the carbohydrate-protein linkage region of chondroitin sulfate proteoglycans of whale cartilage. Eur. J. Biochem. 202 3 (1991) 805-811
210. Sugahara K., Mikami T., Uyama T., Mizuguchi S., Nomura K., and Kitagawa H. Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate. Curr. Opin. Struct. Biol. 13 5 (2003) 612-620
211. Sugahara K., Mizuno N., Okumura Y., and Kawasaki T. The phosphorylated and/or sulfated structure of the carbohydrate-protein-linkage region isolated from chondroitin sulfate in the hybrid proteoglycans of Engelbreth-Holm-Swarm mouse tumor. Eur. J. Biochem. 204 1 (1992) 401-406
212. Sugahara K., Ohi Y., Harada T., de Waard P., and Vliegenthart J.F. Structural studies on sulfated oligosaccharides derived from the carbohydrate-protein linkage region of chondroitin 6-sulfate proteoglycans of shark cartilage. I. Six compounds containing 0 or 1 sulfate and/or phosphate residues. J. Biol. Chem. 267 9 (1992) 6027-6035
213. Sugahara K., Tanaka Y., Yamada S., Seno N., Kitagawa H., Haslam S.M., Morris H.R., and Dell A. Novel sulfated oligosaccharides containing 3-O-sulfated glucuronic acid from king crab cartilage chondroitin sulfate K: Unexpected degradation by chondroitinase ABC. J. Biol. Chem. 271 43 (1996) 26745-26754
214. Sugahara K., Yamada S., Yoshida K., de Waard P., and Vliegenthart J.F. A novel sulfated structure in the carbohydrate-protein linkage region isolated from porcine intestinal heparin. J. Biol. Chem. 267 3 (1992) 1528-1533
215. Sugahara K., Yamashina I., De Waard P., Van Halbeek H., and Vliegenthart J.F. Structural studies on sulfated glycopeptides from the carbohydrate-protein linkage region of chondroitin 4-sulfate proteoglycans of swarm rat chondrosarcoma. Demonstration of the structure Gal(4-O-sulfate)beta 1-3Gal beta 1-4XYL beta 1-O-Ser. J. Biol. Chem. 263 21 (1988) 10168-10174
216. Sugumaran G., Katsman M., and Drake R.R. Purification, photoaffinity labeling, and characterization of a single enzyme for 6-sulfation of both chondroitin sulfate and keratan sulfate. J. Biol. Chem. 270 38 (1995) 22483-22487
217. Sugumaran G., and Silbert J.E. Relationship of sulfation to ongoing chondroitin polymerization during biosynthesis of chondroitin 4-sulfate by microsomal preparations from cultured mouse mastocytoma cells. J. Biol. Chem. 265 30 (1990) 18284-18288
218. Sukegawa K., Nakamura H., Kato Z., Tomatsu S., Montano A.M., Fukao T., Toietta G., Tortora P., Orii T., and Kondo N. Biochemical and structural analysis of missense mutations in N-acetylgalactosamine-6-sulfate sulfatase causing mucopolysaccharidosis IVA phenotypes. Hum. Mol. Genet. 9 9 (2000) 1283-1290
219. Taliani M.R., Agnelli G., Nenci G.G., and Gianese F. Dermatan sulphate in patients with heparin-induced thrombocytopenia. Brit. J. Haematol. 104 1 (1999) 87-89
220. Tam Y.C., and Chan E.C. Purification and characterization of hyaluronidase from oral Peptostreptococcus species. Infect. Immun. 47 2 (1985) 508-513
221. Tanaka M., Maeda N., Noda M., and Marunouchi T. A chondroitin sulfate proteoglycan PTPzeta/RPTPbeta regulates the morphogenesis of Purkinje cell dendrites in the developing cerebellum. J. Neurosci. 23 7 (2003) 2804-2814
222. Thompson L.D., Pantoliano M.W., and Springer B.A. Energetic characterization of the basic fibroblast growth factor-heparin interaction: Identification of the heparin binding domain. Biochemistry 33 13 (1994) 3831-3840
223. Tollefsen D.M., Maimone M.M., McGuire E.A., and Peacock M.E. Heparin cofactor II activation by dermatan sulfate. Ann. N Y Acad. Sci. 556 (1989) 116-122
224. Tovar A.M., de Mattos D.A., Stelling M.P., Sarcinelli-Luz B.S., Nazareth R.A., and Mourao P.A. Dermatan sulfate is the predominant antithrombotic glycosaminoglycan in vessel walls: Implications for a possible physiological function of heparin cofactor II. Biochim. Biophys. Acta 1740 1 (2005) 45-53
225. Trowbridge J.M., and Gallo R.L. Dermatan sulfate: New functions from an old glycosaminoglycan. Glycobiology 12 9 (2002) 117R-125R
226. Trowbridge J.M., Rudisill J.A., Ron D., and Gallo R.L. Dermatan sulfate binds and potentiates activity of keratinocyte growth factor (FGF-7). J. Biol. Chem. 277 45 (2002) 42815-42820
227. Tumova S., Woods A., and Couchman J.R. Heparan sulfate chains from glypican and syndecans bind the Hep II domain of fibronectin similarly despite minor structural differences. J. Biol. Chem. 275 13 (2000) 9410-9417
228. Turnbull J.E., Hopwood J.J., and Gallagher J.T. A strategy for rapid sequencing of heparan sulfate and heparin saccharides. Proc. Natl. Acad. Sci. USA 96 6 (1999) 2698-2703
229. Uchimura K., Kadomatsu K., Nishimura H., Muramatsu H., Nakamura E., Kurosawa N., Habuchi O., El-Fasakhany F.M., Yoshikai Y., and Muramatsu T. Functional analysis of the chondroitin 6-sulfotransferase gene in relation to lymphocyte subpopulations, brain development, and oversulfated chondroitin sulfates. J. Biol. Chem. 277 2 (2002) 1443-1450
230. Umehara Y., Yamada S., Nishimura S., Shioi J., Robakis N.K., and Sugahara K. Chondroitin sulfate of appican, the proteoglycan form of amyloid precursor protein, produced by C6 glioma cells interacts with heparin-binding neuroregulatory factors. FEBS Lett. 557 1-3 (2004) 233-238
231. Unger E.G., Durrant J., Anson D.S., and Hopwood J.J. Recombinant alpha-L-iduronidase: Characterization of the purified enzyme and correction of mucopolysaccharidosis type I fibroblasts. Biochem. J. 304 Pt 1 (1994) 43-49
232. Uyama T., Kitagawa H., Tanaka J., Tamura J., Ogawa T., and Sugahara K. Molecular cloning and expression of a second chondroitin N-acetylgalactosaminyltransferase involved in the initiation and elongation of chondroitin/dermatan sulfate. J. Biol. Chem. 278 5 (2003) 3072-3078
233. Valiyaveettil M., Achur R.N., Muthusamy A., and Gowda D.C. Chondroitin sulfate proteoglycans of the endothelia of human umbilical vein and arteries and assessment for the adherence of Plasmodium falciparum-infected erythrocytes. Mol. Biochem. Parasitol. 134 1 (2004) 115-126
234. Venkataraman G., Sasisekharan V., Cooney C.L., Langer R., and Sasisekharan R. A stereochemical approach to pyranose ring flexibility: Its implications for the conformation of dermatan sulfate. Proc. Natl. Acad. Sci. USA 91 13 (1994) 6171-6175
235. Venkataraman G., Shriver Z., Raman R., and Sasisekharan R. Sequencing complex polysaccharides. Science 286 5439 (1999) 537-542
236. Vertel B.M., Walters L.M., Flay N., Kearns A.E., and Schwartz N.B. Xylosylation is an endoplasmic reticulum to Golgi event. J. Biol. Chem. 268 15 (1993) 11105-11112
237. Vesterberg O. Studies on extracellular proteins from Staphylococcus aureus. 3. Investigations on the heterogeneity of hyaluronate lyase using the method of isoelectric focusing. Biochim. Biophys. Acta 168 2 (1968) 218-227
238. Wadhwa S., Embree M.C., Bi Y., and Young M.F. Regulation, regulatory activities, and function of biglycan. Crit. Rev. Eukaryot. Gene Expr. 14 4 (2004) 301-315
239. Watanabe H., Yamada Y., and Kimata K. Roles of aggrecan, a large chondroitin sulfate proteoglycan, in cartilage structure and function. J. Biochem. (Tokyo) 124 4 (1998) 687-693
240. Wei G., Bai X., Sarkar A.K., and Esko J.D. Formation of HNK-1 determinants and the glycosaminoglycan tetrasaccharide linkage region by UDP-GlcUA:Galactose beta1, 3-glucuronosyltransferases. J. Biol. Chem. 274 12 (1999) 7857-7864
241. Williams C., Hinton D.R., and Miller C.A. Somataglycan-S: A neuronal surface proteoglycan defines the spinocerebellar system. J. Neurochem. 62 4 (1994) 1615-1630
242. Wilson P.J., Meaney C.A., Hopwood J.J., and Morris C.P. Sequence of the human iduronate 2-sulfatase (IDS) gene. Genomics 17 3 (1993) 773-775
243. Winter W.T., Taylor M.G., Stevens E.S., Morris E.R., and Rees D.A. Solid-state 13C NMR and X-ray diffraction of dermatan sulfate. Biochem. Biophys. Res. Commun. 137 1 (1986) 87-93
244. Wisniewski H.G., Snitkin E.S., Mindrescu C., Sweet M.H., and Vilcek J. TSG-6 protein binding to glycosaminoglycans: Formation of stable complexes with hyaluronan and binding to chondroitin sulfates. J. Biol. Chem. 280 15 (2005) 14476-14484
245. Yada T., Gotoh M., Sato T., Shionyu M., Go M., Kaseyama H., Iwasaki H., Kikuchi N., Kwon Y.D., Togayachi A., Kudo T., Watanabe H., et al. Chondroitin sulfate synthase-2: Molecular cloning and characterization of a novel human glycosyltransferase homologous to chondroitin sulfate glucuronyltransferase, which has dual enzymatic activities. J. Biol. Chem. 278 32 (2003) 30235-30247
246. Yada T., Sato T., Kaseyama H., Gotoh M., Iwasaki H., Kikuchi N., Kwon Y.D., Togayachi A., Kudo T., Watanabe H., Narimatsu H., and Kimata K. Chondroitin sulfate synthase-3: Molecular cloning and characterization. J. Biol. Chem. 278 41 (2003) 39711-39725
247. Yamagata T., Saito H., Habuchi O., and Suzuki S. Purification and properties of bacterial chondroitinases and chondrosulfatases. J. Biol. Chem. 243 7 (1968) 1523-1535
248. Yamauchi S., Mita S., Matsubara T., Fukuta M., Habuchi H., Kimata K., and Habuchi O. Molecular cloning and expression of chondroitin 4-sulfotransferase. J. Biol. Chem. 275 12 (2000) 8975-8981
249. Yang Y., Macleod V., Bendre M., Huang Y., Theus A.M., Miao H.Q., Kussie P., Yaccoby S., Epstein J., Suva L.J., Kelly T., and Sanderson R.D. Heparanase promotes the spontaneous metastasis of myeloma cells to bone. Blood 105 3 (2005) 1303-1309
250. Zhang Y., Rauch U., and Perez M.T. Accumulation of neurocan, a brain chondroitin sulfate proteoglycan, in association with the retinal vasculature in RCS rats. Invest. Ophth. Vis. Sci. 44 3 (2003) 1252-1261
251. Zhou X.H., Brakebusch C., Matthies H., Oohashi T., Hirsch E., Moser M., Krug M., Seidenbecher C.I., Boeckers T.M., Rauch U., Buettner R., Gundelfinger E.D., et al. Neurocan is dispensable for brain development. Mol. Cell Biol. 21 17 (2001) 5970-5978
252. Zuo J., Neubauer D., Dyess K., Ferguson T.A., and Muir D. Degradation of chondroitin sulfate proteoglycan enhances the neurite-promoting potential of spinal cord tissue. Exp. Neurol. 154 2 (1998) 654-662
253. Zuo J., Neubauer D., Graham J., Krekoski C.A., Ferguson T.A., and Muir D. Regeneration of axons after nerve transection repair is enhanced by degradation of chondroitin sulfate proteoglycan. Exp. Neurol. 176 1 (2002) 221-228